HowardGMuntzMD

PubMed

• 270 citations
  Uterine papillary serous carcinoma : patterns of metastatic spread
  Barbara A. Goff, Daniel Kato, Rodney A. Schmidt, Marit Ek, Judith A. Ferry
  Gynecologic Oncology. 1994-09-01
• 306 citations
  Ovarian carcinoma diagnosis
  Barbara A. Goff, Lynn Mandel, Howard G. Muntz, Cindy H. Melancon
  Cancer. 2000-11-15
• 90 citations
  Surgical Stage IV Endometrial Carcinoma: A Study of 47 Cases
  Barbara A. Goff, Annekathryn Goodman, Howard G. Muntz, Arlan F. Fuller, Najmosama Nikrui
  Gynecologic Oncology. 1994-02-01

Journal Articles

• We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies  
  Alvarez RD, Gray HJ, Timmins PF 3rd, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown..., Gynecol Oncol, 1/1/2013
• Hydrothorax after robotic-assisted surgical staging of endometrial cancer  
  Sato HR, Muntz HG, Gynecol Oncol Case Rep, 1/1/2012
• Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer  
  McGonigle KF, Muntz HG, Vuky J, Paley PJ, Veljovich DS, Greer BE, Goff BA, Gray HJ, Malpass TW, Cancer, 1/1/2011
• Robot-assisted total laparoscopic hysterectomy in obese and morbidly obese women  
  Rebeles SA, Muntz HG, Wieneke-Broghammer C, Vason ES, McGonigle KF, Journal of Robotic Surgery, 1/1/2009
• Ovarian cancer: recognizing symptoms can make a difference  
  Goff BA, Muntz HG, Contemporary Ob/Gyn, 1/1/2008
• Phase II study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and peritoneal carcinoma  
  Muntz HG, Malpass TW, McGonigle KF, Robertson MD, Weiden PL, Cancer, 1/1/2008
• Ovarian cancer: Patterns of surgical care across the United States  
  Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin L-M, Gynecologic Oncology, 1/1/2006
• Ovarian Cancer Screening  
  Goff BA, Muntz HG, Women’s Health in Primary Care, 1/1/2005
• The significance of psammoma bodies in screening cervical cytology smears  
  Muntz HG, Goff BA, McGonigle K, Isacson C, Am J Obstet Gynecol, 1/1/2003
• Ovarian cancer diagnosis: Results of a national ovarian cancer survey  
  Goff BA, Mandel LS, Muntz HG, Melancom CH, Cancer, 1/1/2000
• Impact of surgical staging in women with locally advanced cervical cancer  
  Goff BA, Muntz HG, Paley PJ, Tamimi HK, Koh W-J, Greer BE, Gynecol Oncol, 1/1/1999
• Port-site recurrence after laparoscopic surgery for endometrial cancer  
  Muntz HG, Goff BA, Madsen BL, Yon JL, Obstet Gynecol, 1/1/1999
• Adenocarcinoma of the uterine cervix metastatic to lymph nodes  
  Cohn DE, Peters WA 3rd, Muntz HG, Wu R, Greer BE, Tamimi HK, Drescher CW, Smith MR, Yon JL, Schmidt R, Goff BA, Am J Obstet Gynecol, 1/1/1998
• Oncogene expression: Long-term compared with short-term survival in patients with advanced epithelial ovarian cancer  
  Goff BA, Muntz HG, Greer BE, Tamimi HK, Gown A, Obstet Gynecol, 1/1/1998
• Uterine papillary serous carcinoma: Evaluation of long-term survival in surgically staged patients  
  Grice J, Marit E, Greer B, Koh WJ, Muntz HG, Cain JM, Tamimi H, Stelzer K, Figge D, Goff BA, Gynecol Oncol, 1/1/1998
• Comparison of 1997 Medicare relative value units for gender-specific procedures: Is Adam still worth more than Eve?  
  Goff BA, Muntz HG, Cain JM, Gynecol Oncol, 1/1/1997
• Is Adam worth more than Eve? The financial impact of gender bias in the federal reimbursement of gynecologic procedures  
  Goff BA, Muntz HG, Cain JM, Gynecol Oncol, 1/1/1997
• Can cervical adenocarcinoma in situ be safely managed by conization alone? (Editorial)  
  Muntz HG, Gynecol Oncol, 1/1/1996
• Overexpression and relationships of HER- 2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian  
  Goff BA, Shy K, Greer BE, Muntz HG, Skelly M, Gown AM, Eur J Gynecol Oncol, 1/1/1996
• Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease  
  Goff BA, Sainz de le Cuesta R, Muntz HG, Fleischhacker D, Ek M, Rice LW, Nikrui N, Tamimi HK, Cain JM, Greer BE, Fuller AF, Jr, Gynecologic Oncology, 1/1/1996
• Expression of epidermal growth factor receptor, p53, her-2/neu, and KI-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcomas  
  Swisher EM, Gown AM, Skelly M, Ek M, Tamimi HK, Cain JM, Greer BE, Muntz HG, Goff BA, Gynecol Oncol, 1/1/1996
• Malignant mixed Mullerian tumors (MMMT) of the ovary: experience with surgical cytoreduction and combination chemotherapy  
  Muntz HG, Jones MA, Goff BA, Rice LW, Nikrui N, Fuller AF, Jr., Tarraza HM, Cancer, 1/1/1995
• Surgical stage IV endometrial carcinoma  
  Goff BA, Rice LW, Muntz HG, Nikrui N, Fuller AF, Jr, Gynecol Oncol, 1/1/1994
• Uterine papillary serous carcinoma: Patterns of metastatic spread  
  Goff BA, Kato D, Schmidt RA, Ek M, Muntz HG, Cain JM, Tamimi HK, Figge DC, Greer BE, Gynecol Oncol, 1/1/1994
• Large loop excision of the transformation zone in patients with exocervical squamous intraepithelial lesions  
  Goff BA, Rice LW, Fleischhacker DS, Abujawadeh GM, Muntz HG, Eur J Gynecol Oncol, 1/1/1994
• Join now to see all

Books/Book Chapters

• Current Care of Women: Diagnosis & Treatment 
  Chapter: Cervical cancer screening and management of the abnormal Papanicolaou smear 
  Page 520 - 531Muntz HGEditors: Lemcke DP, Pattison J, Marshall LA, Cowley DS.McGraw-Hill/Appleton & Lange, New York, NYEdition 2nd,2004
• Atlas of Clinical Gynecology 
  Chapter: Fallopian tube 
  Muntz HGEditors: Goff BA.Current Medicine, Philadelphia, PA1998
• Primary Care of Women 
  Chapter: Cervical cancer screening and management of the abnormal Papanicolaou smear 
  Page 467 - 476Muntz HGEditors: Lemcke DP, Pattison J, Marshall LA, Cowley DS.Appleton & Lange, Norwalk, CT1995
• Atherosclerosis V: Proceedings of the Fifth International Symposium 
  Chapter: Lipoprotein structure and the mechanism of action of lipoprotein lipase 
  Jackson RL, Taskinen MR, Matsuoka N, Fitzharris TJ, Harmony JAK, Muntz HG, Neely EK, Cardin AD, Johnson JDRaven Press, New York1980
• Join now to see all

Abstracts/Posters

• Gynecologic oncology 2015: State of the subspecialty
  Muntz HG, Orr JW, Jr., 46th Annual Meeting of the Society of Gynecologic Oncology, Chicago, IL, 1/30/2015
• Preoperative prediction of uterine morcellation at the time of robotic-assisted hysterectomy
  Sato H, Tiwari A, McGonigle K, Muntz H, Gynecologic Oncology, 1/1/2013
• Leukocytosis after robotic hysterectomy: Commonly observed but clinically insignificant
  Goel M, McGonigle KF, Vason E, Muntz HG, Journal of Robotic Surgery, 39th AAGL Global Congress of Minimally Invasive Gynecology, Las Vegas, NV, 1/1/2010
• Phase II prospective study of weekly topotecan and bevacizumab in platinum refractory ovarian or primary peritoneal cancer
  McGonigle KF, Muntz HG, Vuky J, Paley PJ, Veljovich DS, Gray HJ, Malpass TW, American Society of Clinical Oncology 44th Annual Meeting, 40th Annual Meeting of the Society of Gynecologic Oncology, Chicago, IL, 2008; San Antonio, TX, 2009, 1/5/2009
• IV weekly (days 1 and 8) topotecan in combination with carboplatin (day 1) every 21 days as second-line therapy in subjects with platinum-sensitive relapsed ovarian ca...
  Schwartz P, Rose P, Monk B, Muntz H, Dharan B, Legenne P, Buller R, Sherman L, Starrs E, 15th International Meeting of the European Society of Gynaecological Oncolgy, 1/29/2007
• Mature results of a Phase II study of intraperitoneal topotecan as consolidation therapy in ovarian cancer
  Malpass TW, McGonigle KF, Robertson M, Weiden P, Muntz HG, American Society of Clinical Oncology 43rd Annual Meeting, Chicago, IL, 1/1/2007
• What factors predict comprehensive surgical treatment of ovarian cancer patients?
  Goff B, Larson E, Mathews B, Andrilla H, Lishner D, Baldwin LM, Lackey M, Muntz H, 37th Annual Meeting of the Society of Gynecologic Oncologists, Gynecol Oncol, 1/23/2006
• Phase II study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal cancer
  Muntz HG, McGonigle KD, Malpass TW, Robertson MD, Kamarauskiene D, Weiden P, Society of Gynecologic Oncologists’ 36th Annual Meeting, Cancer Investigation, 1/1/2006
• A high vaginal erosion rate identified in sacrocolpopexy patients using silicone mesh
  Kuznetsov D, Govier F, Kobashi K, Kozlowski P, Begley S, McGonigle K, Muntz H, Society for Urodynamics & Female Urology (SUFU), Scottsdale, AZ, 1/26/2004
• Ovarian cancer symptoms: a randomized trial
  Goff BA, Mandel LS, Melancon CH, Muntz HG, Society of Gynecologic Oncologists, 35th Annual Meeting, San Diego, CA, 1/7/2004
• Phase II study of intraperitoneal topotecan as consolidation therapy in ovarian cancer
  Robertson M, Malpass T, McGonigle K, Weiden P, Muntz H, American Society of Clinical Oncology 40th Annual Meeting, New Orleans, LA, 1/5/2004
• Symptoms of ovarian cancer: how often are they found in women presenting to primary care clinics?
  Goff B, Mandel L, Muntz H, Melancon CH, Society of Gynecologic Oncologists, 34th Annual Meeting, Gynecol Oncol, New Orleans, LA, 1/31/2003
• Evaluation of p27 expression in preinvasive and invasive malignancies of the cervix
  Goff BA, Salin J, Rochelle GL, Vanblaricom A, Paley PJ, Muntz HG, Society of Gynecologic Oncologists, 33rd Annual Meeting, Miami, FL, 1/16/2002
• A phase I, dose-escalation trial of intraperitoneal E1A gene transfer with intravenous carboplatin chemotherapy for treatment of advanced ovarian cancer
  Alberts D, Wolf J, Muntz H, Hatch K, Carrier A, Eggert S, Heald A, Proc Am Soc Clin Oncol, 1/1/2002
• Ovarian cancer diagnosis: Results of a national ovarian cancer survey
  Goff BA, Mandel LS, Muntz HG, Melancon CH, Society of Gynecologic Oncologists, 31st Annual Meeting, San Diego, CA, 1/1/2000
• Impact of surgical staging in women with locally advanced cervical cancer
  Goff BA, Muntz HG, Paley PJ, Tamimi HK, Koh W-J, Greer BE, Society of Gynecologic Oncologists, 30th Annual Meeting, San Francisco, CA, 1/1/1999
• "Curbside" consultations in gynecologic oncology: A closer look at a common practice
  Muntz HG, Society of Gynecologic Oncologists, 30th Annual Meeting, Gynecol Oncol, San Francisco, CA, 1/1/1999
• Is Adam worth more than Eve? The financial impact of gender bias in the federal reimbursement of gynecologic procedures
  Goff BA, Muntz HG, Cain JM, Society of Gynecologic Oncologists, 28th Annual Meeting, 1/1/1997
• Adenocarcinoma-in-situ of the uterine cervix
  Muntz HG, Lage J, Bell DA, Goff BA, Feldman S, Rice LW, Society of Gynecologic Oncologists, 23rd Annual Meeting, San Antonio, TX, 1/1/1992
• Join now to see all

Other

• Ovarian cancer: Recent advances in combination chemotherapy 
  Muntz HG, Virginia Mason Bulletin
  1/1/2005
• Understanding the Natural History of Ovarian Cancer, and the Role of Modern Surgical Management 
  Muntz HG, Virginia Mason Bulletin
  1/1/2004